Business Description
Medlab Clinical Ltd
ISIN : AU000000MDC8
Description
Financial Strength
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | -7.67 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | -916.41 | |||||
Beneish M-Score | -98.9 | |||||
WACC vs ROIC |
Growth Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -86.9 | |||||
3-Year EBITDA Growth Rate | 45.7 | |||||
3-Year EPS without NRI Growth Rate | 47.1 | |||||
3-Year FCF Growth Rate | 76 |
Momentum Rank
4/10
Name | Current | Vs Industry | Vs History |
---|
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.12 | |||||
Quick Ratio | 0.12 | |||||
Cash Ratio | 0.11 | |||||
Days Sales Outstanding | 22893.61 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History |
---|
Profitability Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -18825 | |||||
Net Margin % | -17758.33 | |||||
FCF Margin % | -1383.33 | |||||
ROE % | -993.47 | |||||
ROA % | -176.02 | |||||
ROIC % | -113.2 | |||||
ROC (Joel Greenblatt) % | -211.94 | |||||
ROCE % | -963.8 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 1320 | |||||
EV-to-EBIT | -5.17 | |||||
EV-to-EBITDA | -5.17 | |||||
EV-to-Forward-EBITDA | -0.53 | |||||
EV-to-Revenue | 916.92 | |||||
EV-to-Forward-Revenue | 2.54 | |||||
EV-to-FCF | -66.28 | |||||
Earnings Yield (Greenblatt) % | -19.34 | |||||
FCF Yield % | -1.1 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Medlab Clinical Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil A$) | 0.012 | ||
EPS (TTM) (A$) | -0.93 | ||
Beta | 1.39 | ||
Volatility % | 0 | ||
14-Day RSI | 0 | ||
14-Day ATR (A$) | 0 | ||
20-Day SMA (A$) | 6.6 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range (A$) | 6.6 - 6.6 | ||
Shares Outstanding (Mil) | 2.28 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Medlab Clinical Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Medlab Clinical Ltd Stock Events
Event | Date | Price(A$) | ||
---|---|---|---|---|
No Event Data |
Medlab Clinical Ltd Frequently Asked Questions
What is Medlab Clinical Ltd(ASX:MDC)'s stock price today?
When is next earnings date of Medlab Clinical Ltd(ASX:MDC)?
Does Medlab Clinical Ltd(ASX:MDC) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |